RARE ALERT: Medtronic said to ... - Part 2

The potential takeover of Intersect ENT by Medtronic may have been delayed following interest from a rival party.

Some people following the situation expected Intersect ENT - which manufactures drug-delivery devices used by Ear, Nose & Throat clinicians in the treatment of sinusitis - to unveil a deal last week but an announcement failed to materialise.

Since then, Intersect ENT's shares have dropped signiticantly amid a wider stockmarket sell off...